As we have observed in our April 2026 Advisory regarding Camaisa v. Pharmaceutical Research Associates, Inc. and Fortis Advisors LLC v. Johnson & Johnson and our July 2024 Advisory regarding Trifecta Multimedia Holdings Inc. v. WCG Clinical Services LLC,
Arnold & Porter Kaye Scholer LLP
With nearly 1,000 attorneys, Arnold & Porter provides sophisticated litigation to the life sciences and financial services industries across the globe. Their lawyers cover more than 30 practice areas including corporate finance, intellectual property, litigation, real estate, tax, and bankruptcy. With over 100 years of history, the firm offers clients forward-looking and client driven services to resolve their legal needs.
Website:
https://www.arnoldporter.com/
Arnold & Porter Kaye Scholer LLP Blogs
Latest from Arnold & Porter Kaye Scholer LLP
Claire Reade Discusses U.S.-China Trade Dynamics with Bloomberg TV and CNBC Ahead of Trump-Xi Summit
Claire Reade, Arnold & Porter senior counsel and former Assistant U.S. Trade Representative for China Affairs, appeared on Bloomberg TV’s “Insight with Haslinda Amin” and spoke with CNBC to discuss the state of U.S.-China trade relations ahead of the summit…
Power, Permitting, and Progress: Navigating Today’s Data Center Challenges
Amid a surge in data center demand, communities, policymakers, developers, and energy stakeholders are grappling with increasingly complex environmental, energy, and economic development questions. Join Arnold & Porter and the Business Council for Sustainable Energy (BCSE) for a timely discussion…
Part IV: When National Security Meets Life Sciences: Navigating the Expanding U.S. and European Regulatory Landscapes
National security considerations are rapidly reshaping the life sciences industry, with evolving U.S. and European regulations affecting research, clinical trials, supply chains, investment, data governance, and commercialization. Join Arnold & Porter attorneys for the fourth installment of our National Security…
Final text of the reform to the EU Regulatory Framework for Medicinal Products published
SEC Proposes Proxy Solicitation Modernization
On September 16, 2026, the SEC proposed amendments to modernize certain rules related to proxy solicitations. The proposed amendments would: (i) eliminate the annual report delivery requirement; (ii) eliminate the requirement to send the proxy statement at least 20 business…
S.D.N.Y. Upholds New York’s Social Media Content Moderation Disclosure Law
In a blow to tech industry efforts to challenge state social media regulations, X Corp. (formerly Twitter) lost its challenge to a New York state law requiring social media platforms to disclose content moderation policies. On August 26, 2026, Judge…
Stacey Halliday Weighs In on Oregon EPR Ruling for Corporate Counsel
Stacey Halliday, a partner in Arnold & Porter’s Environmental practice, was quoted in the recent Corporate Counsel article, “Oregon Ruling Gives a Boost to State Recycling Laws,” which examined a federal court ruling upholding Oregon’s extended producer responsibility law against…
Root Causes: Updates and Insights on Quality and Inspections
We are happy to launch a new newsletter, Root Causes: Updates and Insights on Quality and Inspections. The newsletter, which will come out roughly monthly, will discuss new developments in FDA inspections and enforcement, and its regulation of manufacturing and…
Data Protection Update: What In-House Counsel, HR, and Compliance Professionals Need to Know When Dealing With Employees in the UK
We are pleased to invite you to an update webinar on data protection when dealing with employees, covering a raft of recent changes, including The Data (Use and Access) Act 2025 – the most significant reform to UK data protection…